Rheumatology and Therapy
Overview
Rheumatology and Therapy is a scientific journal, published since 2014 in English. The journal's country of origin is United Kingdom and its primary focus area is rehabilitation medicine.
Details
Details
Abbr.
Rheumatol Ther
Start
2014
End
Continuing
Frequency
Two issues a year, 2015-
p-ISSN
2198-6576
e-ISSN
2198-6584
Country
United Kingdom
Language
English
Specialty
Rehabilitation Medicine
Metrics
Metrics
h-index / Ranks: 9569
35
SJR / Ranks: 3364
1071
CiteScore / Ranks: 4778
5.20
JIF / Ranks: 2461
3.8
Recent Articles
1.
2.
Kameda H, Ishii K, Kiriyama J, Mikami T, Uratsuji H, Morita A
Rheumatol Ther
. 2025 Mar;
PMID: 40072816
Introduction: Long-term treatment of psoriatic arthritis (PsA) is required to prevent progression. However, persistence with current treatments is challenging due to tolerability and acceptability issues. The objective of this study...
3.
Jin R, Haughton J, Goddard E, Courmier D, Radziszewski W, Meadows R, et al.
Rheumatol Ther
. 2025 Mar;
PMID: 40064802
Introduction: Biosimilars have provided additional treatment options for patients with immune-mediated inflammatory diseases. This study evaluated the real-world use of adalimumab biosimilar ABP 501 in European patients with rheumatoid arthritis...
4.
Kanda R, Miyazaki Y, Nakayamada S, Fukuyo S, Kubo S, Miyagawa I, et al.
Rheumatol Ther
. 2025 Mar;
PMID: 40025347
Introduction: For patients with rheumatoid arthritis (RA) unresponsive to first-line biologic/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs), the selection of second-line b/tsDMARDs is crucial to prevent progression to difficult-to-treat rheumatoid arthritis...
5.
Avouac J, Ait-Oufella H, Habauzit C, Benkhalifa S, Combe B
Rheumatol Ther
. 2025 Feb;
PMID: 40019616
There is accumulating evidence that inflammation is a key driver of atherosclerosis development and thrombotic complications. This pathophysiological mechanism explains, at least in part, the increased cardiovascular risk of patients...
6.
Kristensen L, McGonagle D, Rudwaleit M, Kameda H, Wurtzen P, Ngantcha M, et al.
Rheumatol Ther
. 2025 Feb;
PMID: 40014255
Introduction: Synovitis and enthesitis are key manifestations in psoriatic arthritis (PsA). This descriptive analysis investigated the association between improvement in synovitis and enthesitis, individually and combined, and improvement in patient-reported...
7.
Crowley A, Siegel L, Grainger R, Webster D, He T, Yang L, et al.
Rheumatol Ther
. 2025 Feb;
PMID: 39976661
Introduction: To evaluate the accuracy, reliability, and usability of Bend Ease, a novel smartphone-based digital health technology (DHT), which objectively self-measures spinal range of motion (SRoM) and remotely assesses morning...
8.
Sicras-Mainar A, Sorio-Vilela F, Sacrest-Soy M, Gatell S, Sicras-Navarro A, Villoro-Valdes R, et al.
Rheumatol Ther
. 2025 Feb;
PMID: 39932674
Introduction: Postmenopausal osteoporosis (PMO) increases the risk of fragility fractures (FF), leading to disability, higher mortality, and elevated healthcare costs. Despite available treatments, osteoporosis (OP) remains undertreated, especially in women...
9.
Shima Y, Uchida-Yamada M, Motegi S, Shimada T, Ishii H, Ohya Y, et al.
Rheumatol Ther
. 2025 Feb;
PMID: 39907912
Introduction: It is important to understand the differences in patient-physician perceptions and factors affecting satisfaction with treatment in patients with systemic sclerosis (SSc). Methods: This web-based survey (conducted in Japan...
10.
Tanaka Y, Horiuchi N, Sasajima C, Matsumoto R, Kawanishi M, Uchida S, et al.
Rheumatol Ther
. 2025 Jan;
PMID: 39869270
Introduction: Ozoralizumab (OZR) is a novel tumor necrosis factor (TNF) inhibitor that was launched in Japan for treating patients with rheumatoid arthritis (RA) who have had an inadequate response to...